Bristol-Myers Squibb Company (BMY) Q1 2009 Earnings Results

Bristol Myers Squibb Beats on EPS, Stock Down 4.3%

Bristol Myers Squibb's earnings report showed a small beat on EPS, but the stock fell by 4.3% in reaction. Investors may be concerned about the lack of revenue details and forward guidance, which could indicate uncertainty about future performance. The cautious tone from management suggests they are aware of challenges ahead, which may have contributed to the stock's decline.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.48	N/A	+1.69%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management conveyed a cautious optimism regarding future growth. They emphasized the need to navigate current market conditions while focusing on innovation.

Management highlighted the importance of ongoing research and development.

They expressed confidence in their pipeline but acknowledged market challenges.

Bristol Myers Squibb Beats on EPS, Stock Down 4.3%

Key numbers

Management commentary

Bristol-Myers Squibb Company

More earnings this week

Bristol Myers Squibb Beats on EPS, Stock Down 4.3%

Key numbers

Management commentary